LN-2201

N/A

Report date: 2024/03/26 18:00:06

Base Information

Drug NameLN-2201
Drug Alias NameLN2201LN-2201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart FailureArrhythmia, Sinus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShandong New Time Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong New Time Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHeart FailureArrhythmia, Sinus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A